SEC 13F Intelligence

Atlas Venture Life Science Advisors, LLC / VIGL

Atlas Venture Life Science Advisors, LLC’s Vigil Neuroscience Inc Position

Does Atlas Venture Life Science Advisors, LLC own Vigil Neuroscience Inc (VIGL)? Not currently — the last reported position was 5.84M shares worth $46M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$46M
Q2 2025
Shares
5.84M
% of Portfolio
+7.01%
Quarters Held
14
position exited

Position History VIGL

Reported value by quarter
Q1 ’22: $41MQ1 ’22Q2 ’22: $15MQ3 ’22: $53MQ3 ’22Q4 ’22: $73MQ1 ’23: $57MQ1 ’23Q2 ’23: $55MQ3 ’23: $31MQ3 ’23Q4 ’23: $20MQ1 ’24: $20MQ1 ’24Q2 ’24: $23MQ3 ’24: $20MQ3 ’24Q4 ’24: $10MQ1 ’25: $10MQ1 ’25Q2 ’25: $46Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20255.84M$46M+7.01%
Q1 20255.84M$10M+1.99%
Q4 20245.84M$10M+1.21%
Q3 20245.84M$20M+1.84%
Q2 20245.84M$23M+2.46%
Q1 20245.84M$20M+1.84%
Q4 20235.84M$20M+2.35%
Q3 20235.84M$31M+4.87%
Q2 20235.84M$55M+6.83%
Q1 20235.84M$57M+7.74%
Q4 20225.84M$73M+8.79%
Q3 20225.84M$53M+5.86%
Q2 20225.84M$15M+2.52%
Q1 20225.84M$41M+5.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlas Venture Life Science Advisors, LLC’s full portfolio or all institutional holders of VIGL.